Location
Suwanee, GA
Start Date
17-4-2026 12:00 PM
End Date
17-4-2026 1:00 PM
Description
Simpson–Golabi–Behmel syndrome (SGBS) is a rare X-linked overgrowth condition characterized by pre- and postnatal macrosomia, craniofacial dysmorphism, congenital anomalies, and increased embryonal tumor risk. We present a 5-year-old male child with genetically confirmed SGBS complicated by progressive inflammatory arthritis consistent with Juvenile Idiopathic Arthritis (JIA), highlighting the diagnostic challenges that arise when structural overgrowth and autoimmune pathology coexist.
The diagnosis of SGBS was initiated prenatally after a mid-trimester anatomy scan demonstrated congenital diaphragmatic hernia and fetal macrosomia. Targeted genetic testing identified a pathogenic variant in GPC3. Postnatally, the child exhibited persistent macrosomia, macroglossia, organomegaly, renal cysts with hypertension, and repaired diaphragmatic hernia. Tumor surveillance was implemented due to increased risk of Wilms tumor and hepatoblastoma.
Despite a well-established genetic diagnosis, progressive joint abnormalities emerged early in life. At 16–18 months, the knees appeared enlarged and gradually lost extension, initially affecting the left side. Over time, swelling involved the ankles, wrists, and small joints of the hands, including prolonged swelling of a digit lasting nearly two years after minor trauma. The patient developed progressive limitation of wrist motion, altered gait mechanics with lateral weight-bearing on the right foot, and pain with ambulation but not at rest. He underwent guided growth surgery to improve knee extension and continues physical therapy with knee, wrist, and ankle bracing. Because articular pathology is not typically anticipated in SGBS, early findings were attributed to structural overgrowth, contributing to diagnostic uncertainty. Initial evaluation was limited to radiographs.
At age four, persistent synovitis, elevated inflammatory markers, and positive antinuclear antibodies prompted rheumatologic evaluation. After exclusion of infectious, malignant, and purely mechanical etiologies—particularly important in a child with an overgrowth syndrome—the patient met clinical criteria for JIA.
The pathophysiology of these conditions is distinct. SGBS results from loss of glypican-3 function, disrupting growth factor signaling pathways such as Hedgehog and Wnt and leading to dysregulated cellular proliferation and tissue overgrowth. In contrast, JIA is an immune-mediated disorder driven by aberrant T-cell activation and pro-inflammatory cytokines (including TNF-α, IL-1, and IL-6), resulting in chronic synovial inflammation and joint damage. While no direct mechanistic association has been established, autoimmune susceptibility may reflect multifactorial influences including genetic predisposition, immune dysregulation, and environmental triggers.
Management required multidisciplinary coordination across genetics, orthopedics, rheumatology, nephrology, oncology surveillance, and rehabilitation services. Anti-inflammatory and disease-modifying therapy was initiated to prevent further joint damage while maintaining tumor surveillance and monitoring for medication-related complications.
This case underscores the importance of avoiding diagnostic anchoring in children with rare genetic syndromes and emphasizes the need to distinguish syndromic structural enlargement from inflammatory arthritis to optimize long-term functional outcomes.
Embargo Period
6-2-2026
Included in
When Overgrowth Masks Inflammation: Juvenile Idiopathic Arthritis in Simpson-Golabi-Behmel Syndrome
Suwanee, GA
Simpson–Golabi–Behmel syndrome (SGBS) is a rare X-linked overgrowth condition characterized by pre- and postnatal macrosomia, craniofacial dysmorphism, congenital anomalies, and increased embryonal tumor risk. We present a 5-year-old male child with genetically confirmed SGBS complicated by progressive inflammatory arthritis consistent with Juvenile Idiopathic Arthritis (JIA), highlighting the diagnostic challenges that arise when structural overgrowth and autoimmune pathology coexist.
The diagnosis of SGBS was initiated prenatally after a mid-trimester anatomy scan demonstrated congenital diaphragmatic hernia and fetal macrosomia. Targeted genetic testing identified a pathogenic variant in GPC3. Postnatally, the child exhibited persistent macrosomia, macroglossia, organomegaly, renal cysts with hypertension, and repaired diaphragmatic hernia. Tumor surveillance was implemented due to increased risk of Wilms tumor and hepatoblastoma.
Despite a well-established genetic diagnosis, progressive joint abnormalities emerged early in life. At 16–18 months, the knees appeared enlarged and gradually lost extension, initially affecting the left side. Over time, swelling involved the ankles, wrists, and small joints of the hands, including prolonged swelling of a digit lasting nearly two years after minor trauma. The patient developed progressive limitation of wrist motion, altered gait mechanics with lateral weight-bearing on the right foot, and pain with ambulation but not at rest. He underwent guided growth surgery to improve knee extension and continues physical therapy with knee, wrist, and ankle bracing. Because articular pathology is not typically anticipated in SGBS, early findings were attributed to structural overgrowth, contributing to diagnostic uncertainty. Initial evaluation was limited to radiographs.
At age four, persistent synovitis, elevated inflammatory markers, and positive antinuclear antibodies prompted rheumatologic evaluation. After exclusion of infectious, malignant, and purely mechanical etiologies—particularly important in a child with an overgrowth syndrome—the patient met clinical criteria for JIA.
The pathophysiology of these conditions is distinct. SGBS results from loss of glypican-3 function, disrupting growth factor signaling pathways such as Hedgehog and Wnt and leading to dysregulated cellular proliferation and tissue overgrowth. In contrast, JIA is an immune-mediated disorder driven by aberrant T-cell activation and pro-inflammatory cytokines (including TNF-α, IL-1, and IL-6), resulting in chronic synovial inflammation and joint damage. While no direct mechanistic association has been established, autoimmune susceptibility may reflect multifactorial influences including genetic predisposition, immune dysregulation, and environmental triggers.
Management required multidisciplinary coordination across genetics, orthopedics, rheumatology, nephrology, oncology surveillance, and rehabilitation services. Anti-inflammatory and disease-modifying therapy was initiated to prevent further joint damage while maintaining tumor surveillance and monitoring for medication-related complications.
This case underscores the importance of avoiding diagnostic anchoring in children with rare genetic syndromes and emphasizes the need to distinguish syndromic structural enlargement from inflammatory arthritis to optimize long-term functional outcomes.